Sources | Names Used |
---|---|
CTRPv2 | Compound 1541A |
PharmacoGx | Compound 1541A |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | RPL39L | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | CDK12 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | CSDC2 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | DENND1B | CTRPv2 | pan-cancer | AAC | 0.11 | 0.01 |
mRNA | ZNF345 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | UTP14A | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
mRNA | GAPVD1 | CTRPv2 | pan-cancer | AAC | 0.1 | 0.01 |
mRNA | DPYSL5 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.01 |
mRNA | TRIM77 | CTRPv2 | pan-cancer | AAC | 0.098 | 0.01 |
mRNA | TK1 | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |